588 related articles for article (PubMed ID: 25956682)
1. Utilization of TALEN and CRISPR/Cas9 technologies for gene targeting and modification.
Pu J; Frescas D; Zhang B; Feng J
Exp Biol Med (Maywood); 2015 Aug; 240(8):1065-70. PubMed ID: 25956682
[TBL] [Abstract][Full Text] [Related]
2. Gene targeting technologies in rats: zinc finger nucleases, transcription activator-like effector nucleases, and clustered regularly interspaced short palindromic repeats.
Mashimo T
Dev Growth Differ; 2014 Jan; 56(1):46-52. PubMed ID: 24372523
[TBL] [Abstract][Full Text] [Related]
3. The iCRISPR platform for rapid genome editing in human pluripotent stem cells.
Zhu Z; González F; Huangfu D
Methods Enzymol; 2014; 546():215-50. PubMed ID: 25398343
[TBL] [Abstract][Full Text] [Related]
4. A Single-Molecule View of Genome Editing Proteins: Biophysical Mechanisms for TALEs and CRISPR/Cas9.
Cuculis L; Schroeder CM
Annu Rev Chem Biomol Eng; 2017 Jun; 8():577-597. PubMed ID: 28489428
[TBL] [Abstract][Full Text] [Related]
5. TALEN or Cas9 - rapid, efficient and specific choices for genome modifications.
Wei C; Liu J; Yu Z; Zhang B; Gao G; Jiao R
J Genet Genomics; 2013 Jun; 40(6):281-9. PubMed ID: 23790627
[TBL] [Abstract][Full Text] [Related]
6. Combining Induced Pluripotent Stem Cells and Genome Editing Technologies for Clinical Applications.
Chang CY; Ting HC; Su HL; Jeng JR
Cell Transplant; 2018 Mar; 27(3):379-392. PubMed ID: 29806481
[TBL] [Abstract][Full Text] [Related]
7. CRISPR-Cas-mediated targeted genome editing in human cells.
Yang L; Mali P; Kim-Kiselak C; Church G
Methods Mol Biol; 2014; 1114():245-67. PubMed ID: 24557908
[TBL] [Abstract][Full Text] [Related]
8. Efficient targeted mutagenesis in soybean by TALENs and CRISPR/Cas9.
Du H; Zeng X; Zhao M; Cui X; Wang Q; Yang H; Cheng H; Yu D
J Biotechnol; 2016 Jan; 217():90-7. PubMed ID: 26603121
[TBL] [Abstract][Full Text] [Related]
9. May I Cut in? Gene Editing Approaches in Human Induced Pluripotent Stem Cells.
Brookhouser N; Raman S; Potts C; Brafman DA
Cells; 2017 Feb; 6(1):. PubMed ID: 28178187
[TBL] [Abstract][Full Text] [Related]
10. Plant genome engineering in full bloom.
Lozano-Juste J; Cutler SR
Trends Plant Sci; 2014 May; 19(5):284-7. PubMed ID: 24674878
[TBL] [Abstract][Full Text] [Related]
11. Gene Editing With CRISPR/Cas9 RNA-Directed Nuclease.
Doetschman T; Georgieva T
Circ Res; 2017 Mar; 120(5):876-894. PubMed ID: 28254804
[TBL] [Abstract][Full Text] [Related]
12. Genome modification by CRISPR/Cas9.
Ma Y; Zhang L; Huang X
FEBS J; 2014 Dec; 281(23):5186-93. PubMed ID: 25315507
[TBL] [Abstract][Full Text] [Related]
13. The application of genome editing in studying hearing loss.
Zou B; Mittal R; Grati M; Lu Z; Shu Y; Tao Y; Feng Y; Xie D; Kong W; Yang S; Chen ZY; Liu X
Hear Res; 2015 Sep; 327():102-8. PubMed ID: 25987504
[TBL] [Abstract][Full Text] [Related]
14. CRISPR-Cas9: a promising tool for gene editing on induced pluripotent stem cells.
Kim EJ; Kang KH; Ju JH
Korean J Intern Med; 2017 Jan; 32(1):42-61. PubMed ID: 28049282
[TBL] [Abstract][Full Text] [Related]
15. Advances in genome editing technology and its promising application in evolutionary and ecological studies.
Chen L; Tang L; Xiang H; Jin L; Li Q; Dong Y; Wang W; Zhang G
Gigascience; 2014; 3():24. PubMed ID: 25414792
[TBL] [Abstract][Full Text] [Related]
16. Genome editing for human gene therapy.
Meissner TB; Mandal PK; Ferreira LM; Rossi DJ; Cowan CA
Methods Enzymol; 2014; 546():273-95. PubMed ID: 25398345
[TBL] [Abstract][Full Text] [Related]
17. [Applications of ZFN, TALEN and CRISPR/Cas9 techniques in disease modeling and gene therapy].
Zhao G; Pu J; Tang B
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2016 Dec; 33(6):857-862. PubMed ID: 27984622
[TBL] [Abstract][Full Text] [Related]
18. Genome Editing of Rat.
Kaneko T
Methods Mol Biol; 2017; 1630():101-108. PubMed ID: 28643253
[TBL] [Abstract][Full Text] [Related]
19. Controlled delivery of β-globin-targeting TALENs and CRISPR/Cas9 into mammalian cells for genome editing using microinjection.
Cottle RN; Lee CM; Archer D; Bao G
Sci Rep; 2015 Nov; 5():16031. PubMed ID: 26558999
[TBL] [Abstract][Full Text] [Related]
20. Development and potential applications of CRISPR-Cas9 genome editing technology in sarcoma.
Liu T; Shen JK; Li Z; Choy E; Hornicek FJ; Duan Z
Cancer Lett; 2016 Apr; 373(1):109-118. PubMed ID: 26806808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
